ACHE and early-onset autosomal dominant Alzheimer disease: Although a number of receptors and target proteins have been studied in Alzheimer's disease (Ul Islam, Khan, Jabir, Kamal & Tabrez, 2017), the only drugs approved for clinical treatment are still acetylcholinesterase inhibitors and memantine.